TrialCancer immunology, immunotherapy : CII2004

Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate.

R Vilella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.